Your browser doesn't support javascript.
loading
Is Conduction System Pacing a Valuable Alternative to Biventricular Pacing for Cardiac Resynchronization Therapy?
Castagno, Davide; Zanon, Francesco; Pastore, Gianni; De Ferrari, Gaetano Maria; Marcantoni, Lina.
Afiliación
  • Castagno D; Division of Cardiology, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • Zanon F; Division of Cardiology, Cardiovascular and Thoracic Department, "Citta della Salute e della Scienza" Hospital, 10126 Turin, Italy.
  • Pastore G; Santa Maria della Misericordia Hospital, Arrhythmia and Electrophysiology Unit, 45100 Rovigo, Italy.
  • De Ferrari GM; Santa Maria della Misericordia Hospital, Arrhythmia and Electrophysiology Unit, 45100 Rovigo, Italy.
  • Marcantoni L; Division of Cardiology, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
J Cardiovasc Dev Dis ; 11(5)2024 May 02.
Article en En | MEDLINE | ID: mdl-38786966
ABSTRACT
Cardiac resynchronization therapy (CRT) significantly improves clinical outcomes in patients with ventricular systolic dysfunction and dyssynchrony. Biventricular pacing (BVP) has a class IA recommendation for patients with symptomatic heart failure with reduced ejection fraction (HFrEF) and left bundle branch block (LBBB). However, approximately 30% of patients have a poor therapeutic response and do not achieve real clinical benefit. Pre-implant imaging, together with tailored programming and dedicated device algorithms, have been proposed as possible tools to improve success rate but have shown inconsistent results. Over the last few years, conduction system pacing (CSP) is becoming a real and attractive alternative to standard BVP as it can restore narrow QRS in patients with bundle branch block (BBB) by stimulating and recruiting the cardiac conduction system, thus ensuring true resynchronization. It includes His bundle pacing (HBP) and left bundle branch area pacing (LBBAP). Preliminary data coming from small single-center experiences are very promising and have laid the basis for currently ongoing randomized controlled trials comparing CSP with BVP. The purpose of this review is to delve into the emerging role of CSP as an alternative method of achieving CRT. After framing CSP in a historical perspective, the pathophysiological rationale and available clinical evidence will be examined, and crucial technical aspects will be discussed. Finally, evidence gaps and future perspectives on CSP as a technique of choice to deliver CRT will be summarized.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Cardiovasc Dev Dis Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Cardiovasc Dev Dis Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza